A Study to Assess the Safety, Tolerability and Pharmacokinetics of BSG005.

Clinical trial NCT04921254 · UNKNOWN

Trial details

NCT number: NCT04921254
Sponsor: Biosergen AS
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Invasive Fungal Infections

Start date: 2021-08-23
Primary completion: 2023-03-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.